SPRING PHARMACEUTICAL GROUP, INC. - FORM 10-K - EX-32 - CERTIFICATE PURSUANT TO 18 U.S.C. SS. 1350 - June 29, 2016

Attached files

file filename
EX-31.1 - RULE 13A-14(A) CERTIFICATE ? CEO - SPRING PHARMACEUTICAL GROUP, INC.exh31_1.htm
10-K - CHINA YCT INTERNATIONAL GROUP, INC. 10K 2016-03-31 - SPRING PHARMACEUTICAL GROUP, INC.china.htm
EX-31.2 - RULE 13A-14(A) CERTIFICATE ? CFO - SPRING PHARMACEUTICAL GROUP, INC.exh31_2.htm
EXHIBIT 32


 Certificate pursuant to 18 U.S.C. ss. 1350
 
In connection with the Annual Report of China YCT International Group, Inc. (the "Company") on Form 10K for the period ending March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

(1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
 (2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 

 
 June 30, 2016
/s/ Yan Tinghe                                      
 
Yan Tinghe, Chief Executive Officer
 
 
June 30, 2016
/s/ Li Chuanmin                                   
 
Li Chuanmin, Chief Financial Officer
 
                                           

SPRING PHARMACEUTICAL GROUP, INC. Reports